Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

MARKET WRAP: Novavax Vaccine, S&P Over 3000, Travel Shares Fly

Published 26/05/2020, 10:32
Updated 25/04/2018, 09:10
  • S&P 500 futures break above 3000 – Novavax coronavirus vaccine offers investors hope
  • Nikkei 225 reaches 10 week high – Japan ends its state of emergency
  • Dollar index (DXY) backs off from 100 level – Economies reopening cuts haven flows
  • Travel stocks fly! (TUI (LON:TUIT) +25%) – Germany considers ending some tourist travel warnings

Novavax Inc (NASDAQ:NVAX) Vaccine

Investors are betting that a vaccine will cure all the market’s ills. News from US pharmaceutical company Novavax that it is ready for human trials of its coronavirus vaccine is reigniting animal spirits. The intial results of the trials will be available in July. The vaccine news has been the spark that was needed to push stock markets above and beyond month-long sideways ranges. Another new vaccine in development offers another path towards the coronavirus endgame.

The S&P 500 is pointing to a move above the important 3000 threshold at the open. It means the US benchmark would reach its highest since early March. Japan’s stock benchmark the Nikkei 225 reached its highest in 10 weeks after Prime Minister Shinzo Abe ended the country’s state of emergency in all cities and regions.

Travel Shares

Healthcare and travel companies were leading the gains across European indices. Virus cases falling after over a month of lifting lockdown restrictions means travel restrictions are the next to go. Austria, Germany and Switzerland had already relaxed travel between their borders. Germany is now considering removing a travel warning to tourists for 31 European destinations. Travel company TUI saw shares surge over 25%. The timing couldn’t be better for travel firms hoping to grab the end of the Summer bookings season.

Dollar Drops

States lifting lockdown measures and Novavax making progress towards another coronavirus vaccine means less need for a haven like the dollar. Gold also fell but remains comfortably above $1700 per oz, cushioned by the weaker dollar. The pullback in the dollar comes as optimism in Europe is building around the €500 billion recovery fund. For the most part currencies have been trading in tight ranges with interest rates pressed to the floor globally.

Chart: Offshore yuan (6-months)

Offshore Yuan (6-Months) Chart

The dollar remains elevated against the yuan over escalating US-China tensions. The exchange rate is testing 7.165 a ceiling to the price since October.

Original Post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.